Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03798847 · ClinicalTrials.gov registry record
Safety and Performance of Journey II XR Total Knee System
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 683
- Enrollment target
NCT03798847: Completed study, sponsored by Smith & Nephew.
NCT03798847 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 683 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03798847 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 683 participants
- Enrollment target
Study Summary
The objective of this study is to estimate the safety and performance of Journey II XR TKS based on retrospective data.
Primary Outcome
Measure of the number of revision cases
Interventions
- DEVICE Journey II XR TKA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 683 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2020-09-10 |
What the finished NCT03798847 record still lists
NCT03798847 is an observational study that tracks outcomes without assigning an intervention. The registered 683 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Journey II XR TKA is the first listed.
NCT03798847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03798847 about?
NCT03798847 is a clinical study titled "Safety and Performance of Journey II XR Total Knee System". The objective of this study is to estimate the safety and performance of Journey II XR TKS based on retrospective data.
What is the current status of trial NCT03798847?
This trial is currently completed. The enrollment target is 683 participants. The study started on 2018-11-01. Estimated completion is 2020-09-10.
What interventions are being tested in trial NCT03798847?
The interventions under investigation include: Journey II XR TKA (DEVICE).
Who is sponsoring clinical trial NCT03798847?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06795087 · 684 participants
Discharge Medication Use Post-Operatively in GU Cancer Patients
- NCT05099770 · 685 participants · Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- NCT05880199 · 685 participants
BSGM to Evaluate Patients With GI Symptoms
- NCT05382559 · 681 participants · Phase 1
A Study of ASP3082 in Adults With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI